GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response
β Scribed by Baishen Chen; Xi Rao; Michael G. House; Kenneth P. Nephew; Kevin J. Cullen; Zhongmin Guo
- Book ID
- 116335673
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 780 KB
- Volume
- 309
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. The promoter of somatostatin (__SST__), a primary inhibitor of gastrinβstimulated gastric acid secretion, is hypermethylated in 80% of human colon cancers. The aim of the current study was to investigate whether and at what stage promoter hypermethylation of __SST__ is i
## Abstract Cell adhesion molecule 1 (CADM1/TSLC1), a putative tumor suppressor involving in cell adhesion, proliferation and apoptosis, is frequently inactivated in several carcinomas due to promoter hypermethylation. But alterations of CADM1/TSLC1 in colorectal carcinogenesis and clinical signifi